Fig. 2.
Fig. 2. Absolute numbers of HSCT in Europe from 1990 to 2000 according to main indications. / (A) Allogeneic transplantations for leukemias, lymphoproliferative disorders, and nonmalignant disorders. (B) Autologous transplantations for leukemias, lymphomas, multiple myelomas, breast cancer, and other solid tumors.

Absolute numbers of HSCT in Europe from 1990 to 2000 according to main indications.

(A) Allogeneic transplantations for leukemias, lymphoproliferative disorders, and nonmalignant disorders. (B) Autologous transplantations for leukemias, lymphomas, multiple myelomas, breast cancer, and other solid tumors.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal